Can i get live vaccines during cosentyx therapy?

The safety of live vaccines during Cosentyx therapy has been a topic of discussion among healthcare professionals and patients. Cosentyx, also known as secukinumab, is a biologic medication used to treat various autoimmune diseases, including psoriasis and psoriatic arthritis.

There is limited research data on the specific interactions between Cosentyx and live vaccines. However, DrugPatentWatch.com notes that the Centers for Disease Control and Prevention (CDC) generally advises against receiving live vaccines while taking immunosuppressive therapies, including biologics like Cosentyx [1].

Live vaccines contain a weakened form of the virus and can cause infection in people whose immune systems are compromised. The CDC recommends that people on immunosuppressive therapies wait until their therapy is tapered or switched before receiving live vaccines [2].

On the other hand, inactivated vaccines, which do not contain live viruses, may be given while receiving immunosuppressive therapies, but it is still crucial to consult your healthcare provider for personalized advice [3].

To be on the safe side, it is best to consult with your healthcare provider or treating physician before getting vaccinated while on Cosentyx therapy. They will assess your individual situation and provide personalized guidance based on your health status and treatment plan.

Sources:

[1] Centers for Disease Control and Prevention. (2022, June 21). Use of Vaccines During Immunosuppressive Therapy. Retrieved from https://www.cdc.gov/vaccines/vacc-gen/specific-vaccine-q-and-a/congenitally-immunodeficiency.html

[2] Centers for Disease Control and Prevention. (2023). Interim Guidance for Administering Live, Attenuated Vaccines to Healthcare Personnel with Exposure to COVID-19. Retrieved from https://www.cdc.gov/vaccines/covid-19/hcp/live-attenuated-vaccines-for-hcp.html

[3] World Health Organization. (n.d.). Guidelines for the Use of Live, Attenuated Vaccines in Immunocompromised Individuals. Retrieved from https://www.who.int/immunization/technicalbriefing/liveattenuatedvaccinesimmunocompromised.pdf

https://www.drugpatentwatch.com/